Download Full Text (2.5 MB)


  • Immune Checkpoint Inhibitors Show Promise Against Metastatic Renal Cell Carcinoma, Other Difficult-to-Treat Cancers: A decade ago, oncologists had little to offer most patients with metastatic renal cell carcinoma (RCC). However, a breakthrough discovery that has already changed the treatment of metastatic melanoma is showing promise against other metastatic cancers-including metastatic RCC-and giving patients new hope for long-term survival
  • Clinical Study Offers Definitive Local Treatment of Bone Metastases from Breast Cancer: Metastatic breast cancer carries a poor prognosis, and most systemic treatments for metastatic disease aim to slow its progression rather than to cure it. In a select group of patients, however, systemic treatment combined with definitive local treatment of the metastatic tumors can offer long-term progression-free survival-and perhaps a cure
  • New Scoring System for Hepatic Reserve Could Help in Planning Treatment for Hepatocellular Carcinoma: An innovative test for evaluating hepatic reserve may improve clinicians' ability to predict prognosis and select appropriate therapy for patients with hepatocellular carcinoma (HCC)
  • INBRIEF: Needle Biopsy Underused in Breast Cancer Diagnosis
  • HOUSE CALL: Managing Stress After cancer Treatment- Communication helps cancer survivors cope with stress

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 59, Number 08, August 2014